Autologous Stem Cell Transplant

Overview

Autologous Transplant is a type of stem cell transplant that utilizes the patient's pre-collected own stem cell to rescue the bone marrow from the toxic effect of a very high dose chemotherapy.

SparkCures ID 21
Generic Name Autologous Stem Cell Transplant
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Verified
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
View Trial
Verified
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell ...
View Trial
Verified
A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-dose Therapy and Autologous Stem Cell T...
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
View Trial
Verified
A Phase I/II Study of Bendamustine and Melphalan conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refract...
View Trial
Verified
Inotuzumab Ozogamicin Post-Transplant for Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
View Trial
Verified
A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ Cells (AMC 097)
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Enhancing Anti-Myeloma Vaccine Response After Autologous Stem Cell Transplantation
View Trial
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
View Trial
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transpl...
View Trial
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the ...
View Trial
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Ste...
View Trial
Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Enhancing Anti-Myeloma Vaccine Response After Autologous Stem Cell Transplantation
View Trial
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
View Trial
Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell ...
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
View Trial
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the ...
View Trial
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell ...
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the ...
View Trial
Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources